Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Practical Pointers"'
Publikováno v:
Clin Diabetes
Diabetes is an independent risk factor for heart failure (HF), with current trends indicating that nearly half of patients with type 2 diabetes will develop this complication. The presence of diabetes also worsens the prognosis of those with HF; peop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58b6d1f0d3af8e30316f6b03df5c3ebc
https://doi.org/10.2337/cd20-0008
https://doi.org/10.2337/cd20-0008
Publikováno v:
Clinical Diabetes : A Publication of the American Diabetes Association
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of incretin-based therapies for the management of hyperglycemia and, in some cases, cardiovascular risk in people with type 2 diabetes. These agents act on multiple physiological pathways
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::266425841e1ed4ef6a3ace639f4630db
https://doi.org/10.2337/cd19-0100
https://doi.org/10.2337/cd19-0100
Autor:
Ji H Cj Chun, Megan S O'Neill
Publikováno v:
Clin Diabetes
Continuous glucose monitoring (CGM) technology has brought about a paradigm shift in defining glycemic control in diabetes management and research. A1C and blood glucose monitoring have been widely accepted measurements in diabetes care, yet each has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e68b83ab5f48016f72e6cbc8404f6645
https://doi.org/10.2337/cd19-0066
https://doi.org/10.2337/cd19-0066
Easing the Financial Burden of Diabetes Management: A Guide for Patients and Primary Care Clinicians
Publikováno v:
Clin Diabetes
More than one in 10 Americans today are living with diabetes (1). To prevent acute and chronic complications of diabetes, including death, patients with diabetes often require multiple medications and medication management supplies to enable effectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aada449097d0a33bd828a99a2d054d7
https://europepmc.org/articles/PMC8603328/
https://europepmc.org/articles/PMC8603328/
Publikováno v:
Clin Diabetes
Pregestational diabetes is a condition in which a woman with diabetes (most commonly type 1 or type 2 diabetes) before the onset of pregnancy becomes pregnant and therefore vulnerable to increased risk for maternal and fetal adverse outcomes. Pregest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbbaba907711df07ba9c4df6295f502b
https://pubmed.ncbi.nlm.nih.gov/34421210
https://pubmed.ncbi.nlm.nih.gov/34421210
Autor:
Kevin Cowart
Publikováno v:
Clin Diabetes
The proportion of patients with type 2 diabetes achieving recommended treatment goals remains suboptimal despite advances in diabetes care (1). Only 30% of patients with type 2 diabetes who use basal insulin achieve an A1C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bee09601457e6929fdd53b24ecd09cb3
https://europepmc.org/articles/PMC7364465/
https://europepmc.org/articles/PMC7364465/
Autor:
Anna Cronin de Chavez, Donald Whitelaw, Maria Berghs, Simon Dyson, Adrian Miller, Fiona Babbington, Karl Atkin
Publikováno v:
Clin Diabetes
The hemoglobin A1c (A1C) test is increasingly used as a diagnostic and screening test for type 2 diabetes. With an estimated 8.8% of adults globally having diabetes, effective screening, diagnosis, and monitoring is of major global importance (1). Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d0a8357f8ebd74e5e8c1970ed4263b1
https://pubmed.ncbi.nlm.nih.gov/31975759
https://pubmed.ncbi.nlm.nih.gov/31975759
Autor:
David Sze, Jennifer Goldman
Publikováno v:
Clinical Diabetes : A Publication of the American Diabetes Association
Human regular U-500 insulin (U-500), a fivefold concentrated form of U-100 regular human insulin, was introduced to address the insulin needs of patients with severe insulin resistance (1). Severe insulin resistance has historically been characterize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bda8da5a2bb0d69abe68e741a989df9
https://doi.org/10.2337/cd18-0004
https://doi.org/10.2337/cd18-0004
Autor:
Kyle R. Peters, Todd Paulsen
Publikováno v:
Clinical Diabetes : A Publication of the American Diabetes Association
The chronic consequences of hyperglycemia in diabetes are well documented. There is evidence that aggressive glycemic control is beneficial in certain populations. Therapy optimization occurs when ineffective medications are adjusted or new medicatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c6616ec0b216cd1249928eabe9d114d
http://europepmc.org/articles/PMC5391812
http://europepmc.org/articles/PMC5391812